ibuprofen in COVID19

Phase 1

Recruiting

• Conditions: COVID 19; Respiratory

• Registration Number: PACTR202202880140319
• Lead Sponsor: ain shams university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-02-07
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1- Age: 18 - 60 years-old both sex
2.moderate case covid 19 diseases

Exclusion Criteria

1- Severe case covid disease.
2.Advanced liver disease.
3- Renal dysfunction.
4- History of peptic ulcer.
5.History of allergy to ibuprofen or paracetamol.
6. Vaccinated patient by any type of vaccine either single or twice dose

Study & Design

• Study Type: Interventional
• Study Design: Not specified